Human PIEZO1 Knockout Cell Line-A549

PIEZO1 is a gene that encodes a protein called piezoelectric mechanosensitive ion channel component 1. PIEZO1 protein is found in many tissues throughout the body, such as blood vessels, kidneys, lungs, and bladder. Structurally, PIEZO1 forms a three-bladed propeller-like structure, as revealed by crystallographic studies. This unique structure is essential for its function, enabling the channel to respond to mechanical stress by changing its conformation. Functionally, PIEZO1 acts as a pore-forming subunit of a mechanosensitive ion channel, allowing the influx of cations, such as calcium ions, upon mechanical stimulation. This gating mechanism has profound consequences for cell physiology, affecting processes as diverse as ion transport across membranes, regulation of cell adhesion, integrin activation, and cellular responses to mechanical stimulation.

PIEZO1 mutations are associated with various genetic diseases. For example, hereditary polycythemia (HX), a rare genetic disease characterized by dehydration of red blood cells. In patients with this disease, certain mutations in PIEZO1 cause overactive ion channels, which results in an imbalance in ion transport, leading to reduced cell size and increased red blood cell fragility. Clinical manifestations of HX include anemia, jaundice, and an increased risk of gallstones. In addition to inherited red blood cell disorders, studies have implicated PIEZO1 in other disorders, such as lymphatic dysplasia. Mutations in PIEZO1 can lead to dysfunction of lymphatic valves, which can result in improper lymphatic flow regulation and lymphedema. Additionally, there is emerging evidence that PIEZO1 may play a role in cancer metastasis, as its mechanosensitive properties affect how cancer cells behave as they migrate and invade new tissues.